Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)

There is no proven preventative therapy or vaccine against COVID-19. Theinfection has spread rapidly and there has already been a substantial adverse impact on the global economy. Healthcare workers have been affected disproportionately in the continuing pandemic. Significant infection rates in this...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Schilling, WHK, Callery, JJ, Taylor, W, Mukaka, M, Ekkapongpisit, M, Watson, JA, Chandna, A, Panapipat, S, Tubprasert, J, Yuentrakul, P, Waithira, N, Cope, T, Dhorda, M, Cruz, C, von Seidlein, L, Milton, J, LLewelyn, M, Adler, A, Chotivanich, K, Cheah, PY, Ashley, EA, Mayxay, M, Dondorp, AM, Phumratanaprapin, W, Day, NPJ, White, N
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	F1000 Research Ltd 2020

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)

Samankaltaisia teoksia